Taeyoung Koo

Kyung Hee Cyber University — South Korea

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index3.6kcitations55works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(29), Virus-based gene therapy research(23), Muscle Physiology and Disorders(18), RNA and protein synthesis mechanisms(6), Retinal Development and Disorders(6)

Publications55 total

Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery
Gene Therapy·2025Open Access
Gene editing in cancer therapy: overcoming drug resistance and enhancing precision medicine
Cancer Gene Therapy·2025· 2 citedOpen Access
Regulation of the tagatose catabolic gene cluster and development of a tagatose-inducible expression system in the probiotic Escherichia coli Nissle 1917
Microbial Cell Factories·2025Open Access
CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer
Molecular Therapy·2024· 13 citedOpen Access
CRISPR base editing-mediated correction of a tau mutation rescues cognitive decline in a mouse model of tauopathy
Translational Neurodegeneration·2024· 8 citedOpen Access
Survivin enhances hippocampal neurogenesis and cognitive function in Alzheimer's disease mouse model
CNS Neuroscience & Therapeutics·2023· 8 citedOpen Access
Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery
Experimental & Molecular Medicine·2023· 16 citedOpen Access
Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations
Molecular Therapy — Nucleic Acids·2022· 16 citedOpen Access
Targeted dual base editing with Campylobacter jejuni Cas9 by a single AAV-mediated delivery
Research Square (Research Square)·2022Open Access
Muscular Dystrophy Therapy Using Viral Vector-based CRISPR/Cas
2022· 3 cited
Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus
Nature Biotechnology·2021· 261 citedOpen Access
Correction to: Recent advances in CRISPR technologies for genome editing
Archives of Pharmacal Research·2021Open Access
Recent advances in CRISPR technologies for genome editing
Archives of Pharmacal Research·2021· 13 cited
CRISPR technologies for the treatment of Duchenne muscular dystrophy
Molecular Therapy·2021· 50 citedOpen Access
CRISPR-Cas12a with an oAd Induces Precise and Cancer-Specific Genomic Reprogramming of EGFR and Efficient Tumor Regression
Molecular Therapy·2020· 26 citedOpen Access
GENETIC THERAPY OF MUSCLE DISEASES: DUCHENNE MUSCULAR DYSTROPHY
WORLD SCIENTIFIC (EUROPE) eBooks·2019
Abstract 861: Precise excision of an oncogenic allele of tumor by Adenovirus-based CRISPR/Cas9 system induces tumor regression
Molecular and Cellular Biology / Genetics·2019
Abstract 861: Precise excision of an oncogenic allele of tumor by Adenovirus-based CRISPR/Cas9 system induces tumor regression
Cancer Research·2019
Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus
Molecular Therapy·2018· 60 citedOpen Access
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Nature Communications·2018· 97 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

George Dickson(14), Jin‐Soo Kim(13), Takis Athanasopoulos(10), Linda Popplewell(9), Alberto Malerba(8), Chae‐Ok Yun(8), Daesik Kim(6), Jin Hyoung Kim(5), Jeong Hun Kim(5), Sung Wook Park(4), Kyoungmi Kim(4), Caroline Le Guiner(4), Laurent Servais(4), Carole Masurier(4), Jean‐Yves Hogrel(4), Oumeya Adjali(4), Fulvio Mavilio(4), A‐Rum Yoon(4), Helen Foster(4), Eunyoung Choi(4)